Global Age-related Macular Degeneration Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
SKU ID : QYR-21623738 | Publishing Date : 07-Sep-2022 | No. of pages : 107
Detailed TOC of Global Age-related Macular Degeneration Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age-related Macular Degeneration Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Age-related Macular Degeneration Market Size (2017-2028)
2.2 Age-related Macular Degeneration Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Age-related Macular Degeneration Market Size by Region (2017-2022)
2.4 Global Age-related Macular Degeneration Market Size Forecast by Region (2023-2028)
2.5 Global Top Age-related Macular Degeneration Countries Ranking by Market Size
3 Age-related Macular Degeneration Competitive by Company
3.1 Global Age-related Macular Degeneration Revenue by Players
3.1.1 Global Age-related Macular Degeneration Revenue by Players (2017-2022)
3.1.2 Global Age-related Macular Degeneration Market Share by Players (2017-2022)
3.2 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Age-related Macular Degeneration Revenue
3.4 Global Age-related Macular Degeneration Market Concentration Ratio
3.4.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2021
3.5 Global Age-related Macular Degeneration Key Players Head office and Area Served
3.6 Key Players Age-related Macular Degeneration Product Solution and Service
3.7 Date of Enter into Age-related Macular Degeneration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Age-related Macular Degeneration Breakdown Data by Type
4.1 Global Age-related Macular Degeneration Historic Revenue by Type (2017-2022)
4.2 Global Age-related Macular Degeneration Forecasted Revenue by Type (2023-2028)
5 Global Age-related Macular Degeneration Breakdown Data by Application
5.1 Global Age-related Macular Degeneration Historic Market Size by Application (2017-2022)
5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Age-related Macular Degeneration Revenue by Company (2020-2022)
6.2 North America Age-related Macular Degeneration Revenue by Type (2017-2028)
6.3 North America Age-related Macular Degeneration Revenue by Application (2017-2028)
6.4 North America Age-related Macular Degeneration Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Age-related Macular Degeneration Revenue by Company (2020-2022)
7.2 Europe Age-related Macular Degeneration Revenue by Type (2017-2028)
7.3 Europe Age-related Macular Degeneration Revenue by Application (2017-2028)
7.4 Europe Age-related Macular Degeneration Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Age-related Macular Degeneration Revenue by Company (2020-2022)
8.2 Asia Pacific Age-related Macular Degeneration Revenue by Type (2017-2028)
8.3 Asia Pacific Age-related Macular Degeneration Revenue by Application (2017-2028)
8.4 Asia Pacific Age-related Macular Degeneration Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Age-related Macular Degeneration Revenue by Company (2020-2022)
9.2 Latin America Age-related Macular Degeneration Revenue by Type (2017-2028)
9.3 Latin America Age-related Macular Degeneration Revenue by Application (2017-2028)
9.4 Latin America Age-related Macular Degeneration Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Age-related Macular Degeneration Revenue by Company (2020-2022)
10.2 Middle East and Africa Age-related Macular Degeneration Revenue by Type (2017-2028)
10.3 Middle East and Africa Age-related Macular Degeneration Revenue by Application (2017-2028)
10.4 Middle East and Africa Age-related Macular Degeneration Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare Age-related Macular Degeneration Products and Services
11.1.4 Bayer HealthCare Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.1.5 Bayer HealthCare Age-related Macular Degeneration SWOT Analysis
11.1.6 Bayer HealthCare Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Products and Services
11.2.4 F. Hoffmann-La Roche Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Age-related Macular Degeneration SWOT Analysis
11.2.6 F. Hoffmann-La Roche Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Age-related Macular Degeneration Products and Services
11.3.4 Novartis Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.3.5 Novartis Age-related Macular Degeneration SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Details
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Products and Services
11.4.4 Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.4.5 Regeneron Pharmaceuticals Age-related Macular Degeneration SWOT Analysis
11.4.6 Regeneron Pharmaceuticals Recent Developments
11.5 Alcon
11.5.1 Alcon Company Details
11.5.2 Alcon Business Overview
11.5.3 Alcon Age-related Macular Degeneration Products and Services
11.5.4 Alcon Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.5.5 Alcon Age-related Macular Degeneration SWOT Analysis
11.5.6 Alcon Recent Developments
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Age-related Macular Degeneration Products and Services
11.6.4 Allergan Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.6.5 Allergan Age-related Macular Degeneration SWOT Analysis
11.6.6 Allergan Recent Developments
11.7 Avalanche
11.7.1 Avalanche Company Details
11.7.2 Avalanche Business Overview
11.7.3 Avalanche Age-related Macular Degeneration Products and Services
11.7.4 Avalanche Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.7.5 Avalanche Age-related Macular Degeneration SWOT Analysis
11.7.6 Avalanche Recent Developments
11.8 Bausch+Lomb
11.8.1 Bausch+Lomb Company Details
11.8.2 Bausch+Lomb Business Overview
11.8.3 Bausch+Lomb Age-related Macular Degeneration Products and Services
11.8.4 Bausch+Lomb Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.8.5 Bausch+Lomb Age-related Macular Degeneration SWOT Analysis
11.8.6 Bausch+Lomb Recent Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Age-related Macular Degeneration Products and Services
11.9.4 Gilead Sciences Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.9.5 Gilead Sciences Age-related Macular Degeneration SWOT Analysis
11.9.6 Gilead Sciences Recent Developments
11.10 Iconic Therapeutics
11.10.1 Iconic Therapeutics Company Details
11.10.2 Iconic Therapeutics Business Overview
11.10.3 Iconic Therapeutics Age-related Macular Degeneration Products and Services
11.10.4 Iconic Therapeutics Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.10.5 Iconic Therapeutics Age-related Macular Degeneration SWOT Analysis
11.10.6 Iconic Therapeutics Recent Developments
11.11 Neurotech Pharmaceuticals
11.11.1 Neurotech Pharmaceuticals Company Details
11.11.2 Neurotech Pharmaceuticals Business Overview
11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Products and Services
11.11.4 Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.11.5 Neurotech Pharmaceuticals Recent Developments
11.12 Ohr Pharmaceutical
11.12.1 Ohr Pharmaceutical Company Details
11.12.2 Ohr Pharmaceutical Business Overview
11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Products and Services
11.12.4 Ohr Pharmaceutical Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022)
11.12.5 Ohr Pharmaceutical Recent Developments
12 Age-related Macular Degeneration Market Dynamics
12.1 Age-related Macular Degeneration Market Trends
12.2 Age-related Macular Degeneration Market Drivers
12.3 Age-related Macular Degeneration Market Challenges
12.4 Age-related Macular Degeneration Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures, Tables and Charts Available in Global Age-related Macular Degeneration Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
List of TablesTable 1. Global Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age-related Macular Degeneration Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Age-related Macular Degeneration Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Age-related Macular Degeneration Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Age-related Macular Degeneration Revenue Market Share by Region (2017-2022)
Table 8. Global Age-related Macular Degeneration Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Age-related Macular Degeneration Market Share by Players (2017-2022)
Table 10. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
Table 11. Ranking of Global Top Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Age-related Macular Degeneration Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Age-related Macular Degeneration Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Age-related Macular Degeneration Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Age-related Macular Degeneration Revenue Market Share by Type (2017-2022)
Table 19. Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Age-related Macular Degeneration Revenue Market Share by Type (2023-2028)
Table 21. Global Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Age-related Macular Degeneration Revenue Market Share by Application (2017-2022)
Table 23. Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Age-related Macular Degeneration Revenue Market Share by Application (2023-2028)
Table 25. North America Age-related Macular Degeneration Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Age-related Macular Degeneration Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Age-related Macular Degeneration Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Age-related Macular Degeneration Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Age-related Macular Degeneration Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Age-related Macular Degeneration Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Age-related Macular Degeneration Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Age-related Macular Degeneration Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Age-related Macular Degeneration Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Age-related Macular Degeneration Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Age-related Macular Degeneration Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Age-related Macular Degeneration Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Age-related Macular Degeneration Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Age-related Macular Degeneration Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Age-related Macular Degeneration Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Age-related Macular Degeneration Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Age-related Macular Degeneration Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Age-related Macular Degeneration Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Age-related Macular Degeneration Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Age-related Macular Degeneration Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Age-related Macular Degeneration Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Age-related Macular Degeneration Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Age-related Macular Degeneration Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Age-related Macular Degeneration Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Age-related Macular Degeneration Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Age-related Macular Degeneration Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Age-related Macular Degeneration Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Age-related Macular Degeneration Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Age-related Macular Degeneration Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Age-related Macular Degeneration Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Age-related Macular Degeneration Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Age-related Macular Degeneration Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Age-related Macular Degeneration Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Age-related Macular Degeneration Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Age-related Macular Degeneration Revenue by Country (2023-2028) & (US$ Million)
Table 60. Bayer HealthCare Company Details
Table 61. Bayer HealthCare Business Overview
Table 62. Bayer HealthCare Age-related Macular Degeneration Product and Services
Table 63. Bayer HealthCare Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 64. Bayer HealthCare Age-related Macular Degeneration SWOT Analysis
Table 65. Bayer HealthCare Recent Developments
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Age-related Macular Degeneration Product and Services
Table 69. F. Hoffmann-La Roche Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 70. F. Hoffmann-La Roche Age-related Macular Degeneration SWOT Analysis
Table 71. F. Hoffmann-La Roche Recent Developments
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Age-related Macular Degeneration Product and Services
Table 75. Novartis Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 76. Novartis Age-related Macular Degeneration SWOT Analysis
Table 77. Novartis Recent Developments
Table 78. Regeneron Pharmaceuticals Company Details
Table 79. Regeneron Pharmaceuticals Business Overview
Table 80. Regeneron Pharmaceuticals Age-related Macular Degeneration Product and Services
Table 81. Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 82. Regeneron Pharmaceuticals Age-related Macular Degeneration SWOT Analysis
Table 83. Regeneron Pharmaceuticals Recent Developments
Table 84. Alcon Company Details
Table 85. Alcon Business Overview
Table 86. Alcon Age-related Macular Degeneration Product and Services
Table 87. Alcon Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 88. Alcon Age-related Macular Degeneration SWOT Analysis
Table 89. Alcon Recent Developments
Table 90. Allergan Company Details
Table 91. Allergan Business Overview
Table 92. Allergan Age-related Macular Degeneration Product and Services
Table 93. Allergan Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 94. Allergan Age-related Macular Degeneration SWOT Analysis
Table 95. Allergan Recent Developments
Table 96. Avalanche Company Details
Table 97. Avalanche Business Overview
Table 98. Avalanche Age-related Macular Degeneration Product and Services
Table 99. Avalanche Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 100. Avalanche Age-related Macular Degeneration SWOT Analysis
Table 101. Avalanche Recent Developments
Table 102. Bausch+Lomb Company Details
Table 103. Bausch+Lomb Business Overview
Table 104. Bausch+Lomb Age-related Macular Degeneration Product and Services
Table 105. Bausch+Lomb Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 106. Bausch+Lomb Age-related Macular Degeneration SWOT Analysis
Table 107. Bausch+Lomb Recent Developments
Table 108. Gilead Sciences Company Details
Table 109. Gilead Sciences Business Overview
Table 110. Gilead Sciences Age-related Macular Degeneration Product and Services
Table 111. Gilead Sciences Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 112. Gilead Sciences Age-related Macular Degeneration SWOT Analysis
Table 113. Gilead Sciences Recent Developments
Table 114. Iconic Therapeutics Company Details
Table 115. Iconic Therapeutics Business Overview
Table 116. Iconic Therapeutics Age-related Macular Degeneration Product and Services
Table 117. Iconic Therapeutics Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 118. Iconic Therapeutics Age-related Macular Degeneration SWOT Analysis
Table 119. Iconic Therapeutics Recent Developments
Table 120. Neurotech Pharmaceuticals Company Details
Table 121. Neurotech Pharmaceuticals Business Overview
Table 122. Neurotech Pharmaceuticals Age-related Macular Degeneration Product and Services
Table 123. Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 124. Neurotech Pharmaceuticals Recent Developments
Table 125. Ohr Pharmaceutical Company Details
Table 126. Ohr Pharmaceutical Business Overview
Table 127. Ohr Pharmaceutical Age-related Macular Degeneration Product and Services
Table 128. Ohr Pharmaceutical Age-related Macular Degeneration Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 129. Ohr Pharmaceutical Recent Developments
Table 130. Age-related Macular Degeneration Market Trends
Table 131. Age-related Macular Degeneration Market Drivers
Table 132. Age-related Macular Degeneration Market Challenges
Table 133. Age-related Macular Degeneration Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age-related Macular Degeneration Sales Market Share by Type: 2021 VS 2028
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-related Macular Degeneration Sales Market Share by Application: 2021 VS 2028
Figure 5. Drugstore Case Studies
Figure 6. Hospital Case Studies
Figure 7. Others Case Studies
Figure 8. Age-related Macular Degeneration Report Years Considered
Figure 9. Global Age-related Macular Degeneration Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Age-related Macular Degeneration Market Size 2017-2028 (US$ Million)
Figure 11. Global Age-related Macular Degeneration Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Age-related Macular Degeneration Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Age-related Macular Degeneration Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Age-related Macular Degeneration Market Share by Players in 2021
Figure 15. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Revenue in 2021
Figure 17. North America Age-related Macular Degeneration Revenue Market Share by Company in 2021
Figure 18. North America Age-related Macular Degeneration Revenue Market Share by Type (2017-2028)
Figure 19. North America Age-related Macular Degeneration Revenue Market Share by Application (2017-2028)
Figure 20. North America Age-related Macular Degeneration Revenue Share by Country (2017-2028)
Figure 21. U.S. Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Age-related Macular Degeneration Revenue Market Share by Company in 2021
Figure 24. Europe Age-related Macular Degeneration Revenue Market Share by Type (2017-2028)
Figure 25. Europe Age-related Macular Degeneration Revenue Market Share by Application (2017-2028)
Figure 26. Europe Age-related Macular Degeneration Revenue Share by Country (2017-2028)
Figure 27. Germany Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 28. France Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Age-related Macular Degeneration Revenue Market Share by Company in 2021
Figure 33. Asia Pacific Age-related Macular Degeneration Revenue Market Share by Type (2017-2028)
Figure 34. Asia Pacific Age-related Macular Degeneration Revenue Market Share by Application (2017-2028)
Figure 35. Asia Pacific Age-related Macular Degeneration Revenue Share by Region (2017-2028)
Figure 36. China Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 37. Japan Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 38. South Korea Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 39. India Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 40. Australia Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 41. Taiwan Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 42. Indonesia Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 43. Thailand Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 44. Malaysia Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 45. Philippines Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 46. Vietnam Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Age-related Macular Degeneration Revenue Market Share by Company in 2021
Figure 48. Latin America Age-related Macular Degeneration Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Age-related Macular Degeneration Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Age-related Macular Degeneration Revenue Share by Country (2017-2028)
Figure 51. Mexico Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Age-related Macular Degeneration Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Age-related Macular Degeneration Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Age-related Macular Degeneration Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Age-related Macular Degeneration Revenue Share by Country (2017-2028)
Figure 58. Turkey Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 60. U.A.E Age-related Macular Degeneration Revenue (2017-2028) & (US$ Million)
Figure 61. Bayer HealthCare Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 64. Regeneron Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 65. Alcon Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 66. Allergan Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 67. Avalanche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 68. Bausch+Lomb Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 69. Gilead Sciences Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 70. Iconic Therapeutics Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 71. Neurotech Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 72. Ohr Pharmaceutical Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Keyplayers in Global Age-related Macular Degeneration Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Bayer HealthCareF. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical
24/7 Research Support
Phone: +1 424 253 0807 
